BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 23583181)

  • 21. Transforming growth factor-β-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression.
    Wendt MK; Smith JA; Schiemann WP
    Oncogene; 2010 Dec; 29(49):6485-98. PubMed ID: 20802523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimetastatic role of Smad4 signaling in colorectal cancer.
    Zhang B; Halder SK; Kashikar ND; Cho YJ; Datta A; Gorden DL; Datta PK
    Gastroenterology; 2010 Mar; 138(3):969-80.e1-3. PubMed ID: 19909744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SIRT1-ZEB1-positive feedback promotes epithelial-mesenchymal transition process and metastasis of osteosarcoma.
    Yu XJ; Guo XZ; Li C; Chong Y; Song TN; Pang JF; Shao M
    J Cell Biochem; 2019 Mar; 120(3):3727-3735. PubMed ID: 30304565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metformin against TGFβ-induced epithelial-to-mesenchymal transition (EMT): from cancer stem cells to aging-associated fibrosis.
    Cufí S; Vazquez-Martin A; Oliveras-Ferraros C; Martin-Castillo B; Joven J; Menendez JA
    Cell Cycle; 2010 Nov; 9(22):4461-8. PubMed ID: 21088486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SIRT7 antagonizes TGF-β signaling and inhibits breast cancer metastasis.
    Tang X; Shi L; Xie N; Liu Z; Qian M; Meng F; Xu Q; Zhou M; Cao X; Zhu WG; Liu B
    Nat Commun; 2017 Aug; 8(1):318. PubMed ID: 28827661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transforming growth factor-β and epithelial-mesenchymal transition are associated with pulmonary metastasis in adenoid cystic carcinoma.
    Dong L; Ge XY; Wang YX; Yang LQ; Li SL; Yu GY; Gao Y; Fu J
    Oral Oncol; 2013 Nov; 49(11):1051-8. PubMed ID: 23962790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-133b and miR-199b knockdown attenuate TGF-β1-induced epithelial to mesenchymal transition and renal fibrosis by targeting SIRT1 in diabetic nephropathy.
    Sun Z; Ma Y; Chen F; Wang S; Chen B; Shi J
    Eur J Pharmacol; 2018 Oct; 837():96-104. PubMed ID: 30125566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation.
    Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY
    Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Construction of SIRT1 gene shRNA lentivirus vector and its effect on the proliferation of breast cancer cells.
    Yue Y; He L; Tian M; Li X
    Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):204-210. PubMed ID: 32538772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lactate Increases Renal Cell Carcinoma Aggressiveness through Sirtuin 1-Dependent Epithelial Mesenchymal Transition Axis Regulation.
    Miranda-Gonçalves V; Lameirinhas A; Macedo-Silva C; Lobo J; C Dias P; Ferreira V; Henrique R; Jerónimo C
    Cells; 2020 Apr; 9(4):. PubMed ID: 32340156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Narrower insight to SIRT1 role in cancer: A potential therapeutic target to control epithelial-mesenchymal transition in cancer cells.
    Choupani J; Mansoori Derakhshan S; Bayat S; Alivand MR; Shekari Khaniani M
    J Cell Physiol; 2018 Jun; 233(6):4443-4457. PubMed ID: 29194618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CTGF siRNA ameliorates tubular cell apoptosis and tubulointerstitial fibrosis in obstructed mouse kidneys in a Sirt1-independent manner.
    Ren Y; Du C; Yan L; Wei J; Wu H; Shi Y; Duan H
    Drug Des Devel Ther; 2015; 9():4155-71. PubMed ID: 26257513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyanidin-3-glucoside induces mesenchymal to epithelial transition via activating Sirt1 expression in triple negative breast cancer cells.
    Liang L; Liu X; He J; Shao Y; Liu J; Wang Z; Xia L; Han T; Wu P
    Biochimie; 2019 Jul; 162():107-115. PubMed ID: 30876970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salinomycin suppresses TGF-β1-induced EMT by down-regulating MMP-2 and MMP-9 via the AMPK/SIRT1 pathway in non-small cell lung cancer.
    Hwang KE; Kim HJ; Song IS; Park C; Jung JW; Park DS; Oh SH; Kim YS; Kim HR
    Int J Med Sci; 2021; 18(3):715-726. PubMed ID: 33437206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of BCL9L in transforming growth factor-β (TGF-β)-induced epithelial-to-mesenchymal-transition (EMT) and metastasis of pancreatic cancer.
    Sannino G; Armbruster N; Bodenhöfer M; Haerle U; Behrens D; Buchholz M; Rothbauer U; Sipos B; Schmees C
    Oncotarget; 2016 Nov; 7(45):73725-73738. PubMed ID: 27713160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FHL2 promotes tubular epithelial-to-mesenchymal transition through modulating β-catenin signalling.
    Cai T; Sun D; Duan Y; Qiu Y; Dai C; Yang J; He W
    J Cell Mol Med; 2018 Mar; 22(3):1684-1695. PubMed ID: 29193729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hydrogen Rich Water Attenuates Renal Injury and Fibrosis by Regulation Transforming Growth Factor-β Induced Sirt1.
    Xing Z; Pan W; Zhang J; Xu X; Zhang X; He X; Fan M
    Biol Pharm Bull; 2017; 40(5):610-615. PubMed ID: 28458345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LncRNA NKILA suppresses TGF-β-induced epithelial-mesenchymal transition by blocking NF-κB signaling in breast cancer.
    Wu W; Chen F; Cui X; Yang L; Chen J; Zhao J; Huang D; Liu J; Yang L; Zeng J; Zeng Z; Pan Y; Su F; Cai J; Ying Z; Zhao Q; Song E; Su S
    Int J Cancer; 2018 Nov; 143(9):2213-2224. PubMed ID: 29761481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resveratrol promotes sensitization to Doxorubicin by inhibiting epithelial-mesenchymal transition and modulating SIRT1/β-catenin signaling pathway in breast cancer.
    Jin X; Wei Y; Liu Y; Lu X; Ding F; Wang J; Yang S
    Cancer Med; 2019 Mar; 8(3):1246-1257. PubMed ID: 30697969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dioscorea alata attenuates renal interstitial cellular fibrosis by regulating Smad- and epithelial-mesenchymal transition signaling pathways.
    Liu SF; Chang SY; Lee TC; Chuang LY; Guh JY; Hung CY; Hung TJ; Hung YJ; Chen PY; Hsieh PF; Yang YL
    PLoS One; 2012; 7(11):e47482. PubMed ID: 23144821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.